The Middle EAST AI In Pharmaceutical Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 4.5 billion by 2034, registering a CAGR of 14.5%. This growth trajectory is underpinned by the increasing integration of artificial intelligence technologies in drug discovery, clinical trials, and personalized medicine. The pharmaceutical sector is witnessing a paradigm shift as...